Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (321-330 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
BMC Infectious Diseases|November 18, 2025
A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C studySamira Hosseini-Hooshyar, Heather Valerio, Erin Flynn, et al.
The International Journal on Drug Policy|August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT studyAnnabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 12, 2019
Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencingArunasingam Abayasingam, Preston Leung, Auda Eltahla, et al.
The Journal of Infectious Diseases|March 14, 2018
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayFrancois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Pageof 37

Showing results (321-330 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
Plos One|April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 studyBehzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 18, 2019
A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infectionsAndrea D Olmstead, Vincent Montoya, Celia K Chui, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
BMC Infectious Diseases|November 18, 2025
A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C studySamira Hosseini-Hooshyar, Heather Valerio, Erin Flynn, et al.
The International Journal on Drug Policy|August 4, 2025
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT studyAnnabelle Stevens, Jake Abbott, Loriate Gribbin, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 12, 2019
Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencingArunasingam Abayasingam, Preston Leung, Auda Eltahla, et al.
The Journal of Infectious Diseases|March 14, 2018
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayFrancois M J Lamoury, Sahar Bajis, Behzad Hajarizadeh, et al.
Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.
Pageof 37